Paul Howard

Paul Howard has extensive experience in the lifesciences venture capital industry. Paul co-founded and served as a managing partner for Mediphase Venture Partners, where they were involved in various investments and served as a board observer. Paul also served on the Board of Directors for Supplemental Health Care and Zyomyx. In addition, they founded TetraPhase Pharmaceuticals and Serenex, where they held leadership positions. Prior to their venture capital career, they worked as an investor at Gilead Sciences and as a Senior Vice President at Hambrecht & Quist Capital Management. Overall, Paul Howard has a strong background in venture capital and has made significant contributions to the lifesciences industry.

Paul Howard has a strong education history in various fields. From 1990 to 1992, they attended the MIT Sloan School of Management and obtained an S.M. degree in Finance & Entrepreneurial studies. Prior to that, from 1981 to 1983, they pursued a Master of Science degree in Food Science & Nutrition at the University of Massachusetts Amherst. Lastly, Paul Howard completed their Bachelor of Arts degree in Biochemistry at Bowdoin College from 1977 to 1981.